MedTrace Logo

3D Ultrasound Breast Imaging

NCT04692818 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2025-12-16

No results posted yet for this study

Summary

The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.

Conditions

  • Breast Tumor

Interventions

DIAGNOSTIC_TEST

GE Logiq E10 clinical ultrasound scanner

2D B-mode, Doppler, and shear wave elastography images of the lesion

DIAGNOSTIC_TEST

Verasonics research scanner

3D B-mode imaging, microvessel imaging, and shear wave elastography

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Shigao Chen, PhD · Mayo Clinic

  • Christine Lee, MD, PhD · Mayo Clinic in Rochester

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-10
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04692818 on ClinicalTrials.gov